ITCI.Intra-cellular Therapies, INC

Form 4: Intra-Cellular Therapies EVP Michael Halstead Reports Stock Transactions

Sentiment:

SEC Form 4 Filing

📋All filings for Intra-cellular Therapies, INC
🔒Login to Follow

EVP and General Counsel of Intra-Cellular Therapies, Michael Halstead, reports the conversion of restricted stock units into common stock.

Summary

  • On March 6, 2024, Michael Halstead, EVP and General Counsel of Intra-Cellular Therapies, reported a transaction involving the conversion of 13,132 restricted stock units into common stock.
  • The restricted stock units convert into common stock on a one-for-one basis.
  • Following the transaction, Halstead directly owns 26,266 derivative securities.
  • The restricted stock units were granted on March 6, 2023, and vest in three equal annual installments beginning on the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: This is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates

DateDescription
03/06/2023Reporting person was granted 39,398 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
03/06/2024Transaction date: Conversion of 13,132 restricted stock units into common stock.
03/08/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.